| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2007 | US7244769 Methods for treating an impairment in memory consolidation |
| 07/17/2007 | US7244768 Side effect reduction |
| 07/17/2007 | US7244767 Therapy for multiple sclerosis, psoriasis, urticaria; antiarthritic agents; incotinence; antitumor, anticancer agents |
| 07/17/2007 | US7244766 Sulfonamide derivatives for the treatment of diseases |
| 07/17/2007 | US7244765 Guanylhydrazone salts, compositions, processes of making and methods of using |
| 07/17/2007 | US7244764 Methods and compositions for treating amyloid-related diseases |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244762 Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates |
| 07/17/2007 | US7244761 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| 07/17/2007 | US7244760 Methods for preparation and use of psorospermin analogs |
| 07/17/2007 | US7244759 For therapy and prophylaxis of cancer, inflammatory bowel disease and myelodysplastic syndrome |
| 07/17/2007 | US7244758 N-type calcium channel blockers |
| 07/17/2007 | US7244757 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 07/17/2007 | US7244756 For increasing blood-brain barrier permeability |
| 07/17/2007 | US7244755 Hydroxypropylamines |
| 07/17/2007 | US7244754 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/17/2007 | US7244751 N-(2-amino-5-fluorophenyl)-4-[N-(Pyridn-3-ylacryloyl)aminomethyl]benzamide or other derivatives for treating cancer and psoriasis |
| 07/17/2007 | US7244749 Mixture of ascorbic acid, niacin, lysine and proline |
| 07/17/2007 | US7244748 Pyridines for treating injured mammalian nerve tissue |
| 07/17/2007 | US7244747 For therapy of epilepsy, epileptogenesis, seizure disorders, convulsions, dyskinesia and neuropathic pain in a mammal |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/17/2007 | US7244744 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels |
| 07/17/2007 | US7244743 Non-peptidic BRS-3 agonists |
| 07/17/2007 | US7244742 Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| 07/17/2007 | US7244741 Fredericamycin derivatives as medicaments for treating tumours |
| 07/17/2007 | US7244740 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| 07/17/2007 | US7244739 For treatment of neurodegenerative disorder, Alzheimer's disease; kits |
| 07/17/2007 | US7244738 Urogenital disorders; sexual diosrders; benign prostatic hyperplasia; analgesics |
| 07/17/2007 | US7244736 useful in the treatment of cancer; taxane-like effects on microtubule polymerization that are not substrates of P-glycoprotein |
| 07/17/2007 | US7244735 useful for treating cancer, neurological disorders, autoimmune disorders, and other diseases that are alleviated by protein kinase inhibitors |
| 07/17/2007 | US7244734 For example, (3R,9aR)-(3,5-bis(trifluoromethyl)phenyl)-[3-(1H-indol-3-ylmethyl)-7-pyridin-3-yl-1,3,4,8,9,9a-hexahydro-pyrido[1,2-a]pyrazin-2-yl]-methanone; useful in the treatment of disorders in which neurokinins which interact with NK1 receptors, e.g. neurokinin-1 (=Substance P) are involved |
| 07/17/2007 | US7244733 N-(4-Chlorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1; angiogenesis inhibitors; anticancer agents; diseases associated with signal transduction pathways operating through growth factor receptors |
| 07/17/2007 | US7244732 Prodrugs of heteroaryl compounds |
| 07/17/2007 | US7244731 preparing 6-methyl-2-[4-(4-morpholino)anilino]nicotinic acid by reacting 2-chloro-6-methylnicotinic acid with 4-(4-morforino)aniline; effective for inhibiting the replication of hepatitis C virus |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244729 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur |
| 07/17/2007 | US7244728 Long acting betamimetics for the treatment of respiratory diseases |
| 07/17/2007 | US7244727 Fused bicyclic nitrogen-containing heterocycles |
| 07/17/2007 | US7244726 Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy |
| 07/17/2007 | US7244725 treatment of Alzheimer's disease and more specifically compounds that are capable of inhibiting beta-secretase |
| 07/17/2007 | US7244724 Pyrrolobenzodiazepines |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 07/17/2007 | US7244720 Soluble forms of amoxicillin and treatment of animals |
| 07/17/2007 | US7244719 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses |
| 07/17/2007 | US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog |
| 07/17/2007 | US7244717 Mutagenic nucleoside analogs for the treatment of viral disease |
| 07/17/2007 | US7244716 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS |
| 07/17/2007 | US7244714 Methods of delivering aerosolized polynucleotides to the respiratory tract |
| 07/17/2007 | US7244713 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(2'-trimethylsilylethyn-1-yl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C; viricide mixture contains other active drugs |
| 07/17/2007 | US7244712 Aminoglycoside antibiotics and methods of using same |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244709 comprising an aqueous mixture of parathyroid hormone, a cyclodextran and didecanoylphosphatidylcholine at concentrations sufficient to enhance permeation across the cellular layer, wherein the formulation consists of droplets, of which less than 10% are less than 10 microns in diameter |
| 07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
| 07/17/2007 | US7244706 For therapy of bacterial infections |
| 07/17/2007 | US7244703 Pharmaceutical compositions and methods for peptide treatment |
| 07/17/2007 | US7244450 coadministration of liposome-encapsulated vincristine with Rituximab; anticarcinogenic agents; relapsed non-Hodgkin's Lymphoma |
| 07/17/2007 | US7244449 Liposome-entrapped topoisomerase inhibitors |
| 07/17/2007 | US7244448 Providing liposome having free active agent and precipitated active agent encapsulated therein; varying amount of active agent that is precipitated in liposome for modulation plasma circulation half-life of active agent |
| 07/17/2007 | US7244447 Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
| 07/17/2007 | US7244446 Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
| 07/17/2007 | US7244444 Graft material, stent graft and method |
| 07/17/2007 | US7244440 artificial tears or vehicles for ophthalmic drugs; viscosity; hydroxypropyl methylcellulose and a combination of two other polymers: guar gum, a carboxyvinyl polymer (polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol), hydroxyethyl cellulose or dextran |
| 07/17/2007 | US7244438 Uses for polycationic compounds |
| 07/17/2007 | US7244432 A VP2 protein isolated from a variant Georgia strain of IBDV for use in reducing or preventing infection in poultry |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244418 For therapy of microbial infection of a nail plate |
| 07/17/2007 | US7244417 Containing as a stabilizer a di(C 6-24 branched or unbranched alkyl) 2,6-naphthalenedicarboxylate and a wax or oil thickener, for use in cosmetic or dermatological formulations. |
| 07/17/2007 | US7244415 Suspension of crystalline tiotropium bromide anhydrate in the propellant gases HFA 227 and/or HFA 134a |
| 07/17/2007 | US7244414 Administering fine powder of active material; measured aerosol |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2485834C Pseudopolymorphic forms of a hiv protease inhibitor |
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2389235C Controlled release hydrocodone formulations |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/17/2007 | CA2348767C Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 07/17/2007 | CA2321369C Dosing regimens for lasofoxifene |
| 07/17/2007 | CA2306628C Cosmetic formulations for the prevention and therapy of hair loss |
| 07/17/2007 | CA2303389C Antimicrobial quinolones, their compositions and uses |
| 07/17/2007 | CA2300339C Transdermal therapeutic system containing the active substance scopolamine base |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 07/17/2007 | CA2285542C N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 07/17/2007 | CA2284501C Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 07/17/2007 | CA2283198C Butyrate prodrugs derived from lactic acid |
| 07/17/2007 | CA2254958C Methods for sterilizing female mammals |
| 07/17/2007 | CA2254528C Treatment of ischemia reperfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction |
| 07/17/2007 | CA2253187C Use of tempol in the prevention of photoaging |
| 07/17/2007 | CA2240060C O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
| 07/17/2007 | CA2233016C Anthelmintic macrocyclic lactone compositions |
| 07/17/2007 | CA2223898C Brominated hexahydroxybiphenyl derivatives |
| 07/17/2007 | CA2187186C Stable aqueous folinate solution |
| 07/17/2007 | CA2172506C Mycophenolate mofetil and mycophenolic acid high dose oral suspensions |
| 07/17/2007 | CA2170879C Diagnostic uses of hydrazinoadenosines |
| 07/17/2007 | CA2160161C Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |